Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to -$241000.0.

  • IceCure Medical's Net Cash Flow fell 12383.78% to -$241000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.6 million, marking a year-over-year decrease of 18380.45%. This contributed to the annual value of -$2.9 million for FY2024, which is 7772.03% up from last year.
  • Latest data reveals that IceCure Medical reported Net Cash Flow of -$241000.0 as of Q3 2025, which was down 12383.78% from -$749000.0 recorded in Q2 2025.
  • In the past 5 years, IceCure Medical's Net Cash Flow registered a high of $11.6 million during Q1 2021, and its lowest value of -$18.1 million during Q1 2023.
  • In the last 5 years, IceCure Medical's Net Cash Flow had a median value of -$749000.0 in 2025 and averaged $100052.6.
  • Over the last 5 years, IceCure Medical's Net Cash Flow had its largest YoY gain of 80117.24% in 2021, and its largest YoY loss of 305631.07% in 2021.
  • Over the past 5 years, IceCure Medical's Net Cash Flow (Quarter) stood at $10.2 million in 2021, then rose by 9.41% to $11.1 million in 2022, then plummeted by 41.76% to $6.5 million in 2023, then plummeted by 147.86% to -$3.1 million in 2024, then skyrocketed by 92.23% to -$241000.0 in 2025.
  • Its Net Cash Flow was -$241000.0 in Q3 2025, compared to -$749000.0 in Q2 2025 and -$1.5 million in Q1 2025.